Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/4/893 |
_version_ | 1797436776275509248 |
---|---|
author | Krzysztof Bonek Ewa Kuca Warnawin Anna Kornatka Magdalena Plebańczyk Tomasz Burakowski Włodzimierz Maśliński Małgorzata Wisłowska Piotr Głuszko Marzena Ciechomska |
author_facet | Krzysztof Bonek Ewa Kuca Warnawin Anna Kornatka Magdalena Plebańczyk Tomasz Burakowski Włodzimierz Maśliński Małgorzata Wisłowska Piotr Głuszko Marzena Ciechomska |
author_sort | Krzysztof Bonek |
collection | DOAJ |
description | This study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>n</i> = 25, RA <i>n</i> = 15) and 25 healthy controls (HC) were enrolled into the study. The expression of miR-223-5p, miR-92b-3p, miR-485-3p, miR-10b-5p, let-7d-5p, miR-26a-2-3p, miR-146b-3p, and cytokines levels were measured in sera. DIANA-mirPath analysis was used to predict pathways targeted by the dysregulated miRs. Disease activity scores were calculated. Lipid profile, uric acid, glucose level, and C-reactive protein (CRP) concentrations were determined in the blood. Based on lipid profiles, the PsA group had hypertriglyceridaemia, and RA patients revealed mixed dyslipidaemia, while in AS, no specific changes were found. miR expression analysis revealed upregulation of miR-26a-2-3p and miR-10b-5p in PsA, miR-485-3p in AS, and let-7d-5p in RA. Several correlations between disease activity indexes, metabolites levels, and expression of miRs were observed in PsA, RA, and AS patients. Finally, in ROC analysis, miR-26a-2-3p/miR-485-3p, and let-7d-5p/miR-146b-3p tandems revealed high sensitivity and specificity in distinguishing between PsA, AS, and RA. Our study illustrates the superiority of miR expressions in distinguishing between RA, PsA, and AS. In PsA, a unique regulatory pathway exists through miR-26a-2-3p, miR-223-5p, miR-10b-5p, and miR-92b-3p that converges proatherogenic metabolism and disease activity. |
first_indexed | 2024-03-09T11:07:29Z |
format | Article |
id | doaj.art-c820b100d9fb42f2b99caa6adedd09fd |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-09T11:07:29Z |
publishDate | 2022-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-c820b100d9fb42f2b99caa6adedd09fd2023-12-01T00:54:59ZengMDPI AGBiomedicines2227-90592022-04-0110489310.3390/biomedicines10040893Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis PatientsKrzysztof Bonek0Ewa Kuca Warnawin1Anna Kornatka2Magdalena Plebańczyk3Tomasz Burakowski4Włodzimierz Maśliński5Małgorzata Wisłowska6Piotr Głuszko7Marzena Ciechomska8Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandThis study aimed to investigate the associations of microRNA (miRs) signatures with cytokines, serum lipids, and disease activity in patients with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). In total, 65 patients (PsA <i>n</i> = 25, AS <i>n</i> = 25, RA <i>n</i> = 15) and 25 healthy controls (HC) were enrolled into the study. The expression of miR-223-5p, miR-92b-3p, miR-485-3p, miR-10b-5p, let-7d-5p, miR-26a-2-3p, miR-146b-3p, and cytokines levels were measured in sera. DIANA-mirPath analysis was used to predict pathways targeted by the dysregulated miRs. Disease activity scores were calculated. Lipid profile, uric acid, glucose level, and C-reactive protein (CRP) concentrations were determined in the blood. Based on lipid profiles, the PsA group had hypertriglyceridaemia, and RA patients revealed mixed dyslipidaemia, while in AS, no specific changes were found. miR expression analysis revealed upregulation of miR-26a-2-3p and miR-10b-5p in PsA, miR-485-3p in AS, and let-7d-5p in RA. Several correlations between disease activity indexes, metabolites levels, and expression of miRs were observed in PsA, RA, and AS patients. Finally, in ROC analysis, miR-26a-2-3p/miR-485-3p, and let-7d-5p/miR-146b-3p tandems revealed high sensitivity and specificity in distinguishing between PsA, AS, and RA. Our study illustrates the superiority of miR expressions in distinguishing between RA, PsA, and AS. In PsA, a unique regulatory pathway exists through miR-26a-2-3p, miR-223-5p, miR-10b-5p, and miR-92b-3p that converges proatherogenic metabolism and disease activity.https://www.mdpi.com/2227-9059/10/4/893miRNApsoriatic arthritisrheumatoid arthritisankylosing spondylitisinflammationlipids |
spellingShingle | Krzysztof Bonek Ewa Kuca Warnawin Anna Kornatka Magdalena Plebańczyk Tomasz Burakowski Włodzimierz Maśliński Małgorzata Wisłowska Piotr Głuszko Marzena Ciechomska Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients Biomedicines miRNA psoriatic arthritis rheumatoid arthritis ankylosing spondylitis inflammation lipids |
title | Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients |
title_full | Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients |
title_fullStr | Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients |
title_full_unstemmed | Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients |
title_short | Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients |
title_sort | circulating mirna correlates with lipid profile and disease activity in psoriatic arthritis rheumatoid arthritis and ankylosing spondylitis patients |
topic | miRNA psoriatic arthritis rheumatoid arthritis ankylosing spondylitis inflammation lipids |
url | https://www.mdpi.com/2227-9059/10/4/893 |
work_keys_str_mv | AT krzysztofbonek circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT ewakucawarnawin circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT annakornatka circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT magdalenaplebanczyk circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT tomaszburakowski circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT włodzimierzmaslinski circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT małgorzatawisłowska circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT piotrgłuszko circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients AT marzenaciechomska circulatingmirnacorrelateswithlipidprofileanddiseaseactivityinpsoriaticarthritisrheumatoidarthritisandankylosingspondylitispatients |